THE RAPID REDUCTION IN CARDIAC EVENTS WITH LIPID-LOWERING THERAPY - MECHANISMS AND IMPLICATIONS

被引：19

作者：

PEARSON, TA ^{[1
]}

MARX, HJ ^{[1
]}

机构：

[1] COLUMBIA UNIV,NEW YORK,NY 10027

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1993年 / 72卷 / 14期

关键词：

D O I：

10.1016/0002-9149(93)90864-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1072 / 1073

页数：2

共 15 条

[1]

[Anonymous], 1993, AM J CARDIOL, V72, P1031

[2] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].

BLANKENHORN, DH ;

NESSIM, SA ;

JOHNSON, RL ;

SANMARCO, ME ;

AZEN, SP ;

CASHINHEMPHILL, L .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240

[3] REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].

BROWN, G ;

ALBERS, JJ ;

FISHER, LD ;

SCHAEFER, SM ;

LIN, JT ;

KAPLAN, C ;

ZHAO, XQ ;

BISSON, BD ;

FITZPATRICK, VF ;

DODGE, HT .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298

[4] EFFECT OF PARTIAL ILEAL BYPASS-SURGERY ON MORTALITY AND MORBIDITY FROM CORONARY HEART-DISEASE IN PATIENTS WITH HYPERCHOLESTEROLEMIA - REPORT OF THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) [J].

BUCHWALD, H ;

VARCO, RL ;

MATTS, JP ;

LONG, JM ;

FITCH, LL ;

CAMPBELL, GS ;

PEARCE, MB ;

YELLIN, AE ;

EDMISTON, WA ;

SMINK, RD ;

SAWIN, HS ;

CAMPOS, CT ;

HANSEN, BJ ;

TUNA, N ;

KARNEGIS, JN ;

SANMARCO, ME ;

AMPLATZ, K ;

CASTANEDAZUNIGA, WR ;

HUNTER, DW ;

BISSETT, JK ;

WEBER, FJ ;

STEVENSON, JW ;

LEON, AS ;

CHALMERS, TC .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :946-955

[5] ATHEROSCLEROSIS OR LIPOPROTEIN-INDUCED ENDOTHELIAL DYSFUNCTION - POTENTIAL MECHANISMS UNDERLYING REDUCTION IN EDRF/NITRIC OXIDE ACTIVITY [J].

FLAVAHAN, NA .

CIRCULATION, 1992, 85 (05) :1927-1938

[6] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[7] COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITION FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE [J].

GOLDMAN, L ;

WEINSTEIN, MC ;

GOLDMAN, PA ;

WILLIAMS, LW .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (09) :1145-1151

[8] HEALTH-POLICY ON BLOOD CHOLESTEROL - TIME TO CHANGE DIRECTIONS [J].

HULLEY, SB ;

WALSH, JMB ;

NEWMAN, TB .

CIRCULATION, 1992, 86 (03) :1026-1029

[9] SHOULD WE BE MEASURING BLOOD CHOLESTEROL LEVELS IN YOUNG-ADULTS [J].

HULLEY, SB ;

NEWMAN, TB ;

GRADY, D ;

GARBER, AM ;

BARON, RB ;

BROWNER, WS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (11) :1416-1419

[10] CHOLESTEROL LOWERING AS A TREATMENT FOR ESTABLISHED CORONARY HEART-DISEASE [J].

LAROSA, JC ;

CLEEMAN, JI .

CIRCULATION, 1992, 85 (03) :1229-1235

← 1 2 →